<MedicationStatement xmlns="http://hl7.org/fhir">
   <id value="MBH-T2-2-P2-4-MGB1"/>
   <meta>
      <profile value="http://nictiz.nl/fhir/StructureDefinition/zib-MedicationUse"/>
   </meta>
   <text>
      <status value="generated"/>
      <div xmlns="http://www.w3.org/1999/xhtml">
         <table>
            <caption>MedicationStatement. Subject: <a href="Patient/XXX-Bals">A XXX_Bals</a>Id: MBH_T2.2_P2_4_MGB1 (urn:oid:2.16.840.1.113883.2.4.3.11.999.77.6.1), Categorie: <span title="Medicatiegebruik (6 - 2.16.840.1.113883.2.4.3.11.60.20.77.5.3)">Medicatiegebruik</span>, Status: <i>onbekend (ontbrekend gegeven)</i>
               <br/>Auteur: <a href="Patient/XXX-Bals">A XXX_Bals</a>
            </caption>
            <tbody>
               <tr>
                  <th>Medicamenteuze behandel-id</th>
                  <td>MBH_T2.2_P2_4 (urn:oid:2.16.840.1.113883.2.4.3.11.999.77.1.1)</td>
               </tr>
               <tr>
                  <th>Medicatie</th>
                  <td>
                     <a href="Medication/OTRIVINNEUSALLERGIEAZELASTINENEUSSPRAY1MGML">OTRIVIN NEUSALLERGIE AZELASTINE NEUSSPRAY 1MG/ML</a>
                  </td>
               </tr>
               <tr>
                  <th>Datum/tijd</th>
                  <td>[Language: en]15 September 2018 10:00:00 - [Language: en]20 September 2018 21:00:00</td>
               </tr>
               <tr>
                  <th>Medicatie gebruikt</th>
                  <td>nee</td>
               </tr>
            </tbody>
         </table>
      </div>
   </text>
   <extension url="http://nictiz.nl/fhir/StructureDefinition/zib-MedicationUse-Author">
      <valueReference>
         <reference value="Patient/XXX-Bals"/>
         <display value="A XXX_Bals"/>
      </valueReference>
   </extension>
   <extension url="http://nictiz.nl/fhir/StructureDefinition/zib-Medication-MedicationTreatment">
      <valueIdentifier>
         <system value="urn:oid:2.16.840.1.113883.2.4.3.11.999.77.1.1"/>
         <value value="MBH_T2.2_P2_4"/>
      </valueIdentifier>
   </extension>
   <extension url="http://nictiz.nl/fhir/StructureDefinition/zib-Medication-InstructionsForUseDescription">
      <valueString value="Vanaf 15 sep 2018, t/m 20 sep 2018, twee keer per dag één spray in elk neusgat"/>
   </extension>
   <identifier>
      <system value="urn:oid:2.16.840.1.113883.2.4.3.11.999.77.6.1"/>
      <value value="MBH_T2.2_P2_4_MGB1"/>
   </identifier>
   <status>
      <extension url="http://hl7.org/fhir/StructureDefinition/data-absent-reason">
         <valueCode value="unknown"/>
      </extension>
   </status>
   <category>
      <coding>
         <system value="urn:oid:2.16.840.1.113883.2.4.3.11.60.20.77.5.3"/>
         <code value="6"/>
         <display value="Medicatiegebruik"/>
      </coding>
      <text value="Medicatiegebruik"/>
   </category>
   <medicationReference>
      <reference value="Medication/OTRIVINNEUSALLERGIEAZELASTINENEUSSPRAY1MGML"/>
      <display value="OTRIVIN NEUSALLERGIE AZELASTINE NEUSSPRAY 1MG/ML"/>
   </medicationReference>
   <effectivePeriod>
      <start value="2018-09-15T10:00:00+02:00"/>
      <end value="2018-09-20T21:00:00+02:00"/>
   </effectivePeriod>
   <subject>
      <reference value="Patient/XXX-Bals"/>
      <display value="A XXX_Bals"/>
   </subject>
   <taken value="n"/>
</MedicationStatement>
